Med Ad News | Jotup

Steven Michaelson, Founder and Chairman, Announces Retirement from Calcium + Company

Retrieved on:

Tuesday, March 7, 2023

NEW YORK, March 7, 2023 /PRNewswire/ -- Steven Michaelson, a four-decade advertising and marketing veteran who founded two celebrated agencies during his career—Wishbone (1998) and Calcium (2012)—has announced his retirement from Calcium + Company.

Key Points:

NEW YORK, March 7, 2023 /PRNewswire/ -- Steven Michaelson, a four-decade advertising and marketing veteran who founded two celebrated agencies during his career—Wishbone (1998) and Calcium (2012)—has announced his retirement from Calcium + Company.
He will do whatever it takes and make it happen," explained Judy Capano, Mr. Michaelson's long-time business partner and wife, and current Calcium + Company CEO.
Some of my other partners, like Steve Hamburg, Chief Strategy Officer, followed me from Wishbone to Calcium.
This is a team sport, and I couldn't have done it without all the incredible people at both Wishbone and Calcium.

Heartbeat Selected for Ad Age Best Places to Work 2023 List, Celebrates 7 Consecutive Years of Workplace Honors

Retrieved on:

Monday, January 23, 2023

Heartbeat, The Last Best Place, D&I, Marketing, Culture, Advertising, Publicis, Environment, Digitas Health, News, Med Ad News, D, Health, 100 Best Companies to Work For, Organization, Courage, Bofors 57 mm m/47 aircraft gun, Nursing, Creative industries

NEW YORK, Jan. 23, 2023 /PRNewswire-PRWeb/ -- Leading healthcare marketing agency Heartbeat has been named to the 2023 Ad Age Best Places to Work list, ranking 2 overall in the large agency category. 2023 marks the 3rd consecutive year, and 4th overall, that Heartbeat has been recognized as part of the prestigious Ad Age listing.

Key Points:

NEW YORK, Jan. 23, 2023 /PRNewswire-PRWeb/ -- Leading healthcare marketing agency Heartbeat has been named to the 2023 Ad Age Best Places to Work list, ranking 2 overall in the large agency category.
2023 marks the 3rd consecutive year, and 4th overall, that Heartbeat has been recognized as part of the prestigious Ad Age listing.
The Ad Age Best Places to Work program is an annual ranking of companies that lead the pack in factors ranging from pay and benefits to corporate culture and leadership.
In addition to previous Best Places to Work selections from Ad Age (2017, 2021, and 2022), Heartbeat is also a 3-time selectee to the MM+M Best Places to Work list (2018, 2019, and 2021).

Heartbeat Named to "Inclusive Workplace" List by Best Companies Group

Retrieved on:

Tuesday, January 10, 2023

News, Med Ad News, Organization, COLOR, Human, Culture, Health insurance, Management

NEW YORK, Jan. 10, 2023 /PRNewswire-PRWeb/ -- Leading healthcare marketing agency Heartbeat has been recognized as an "Inclusive Workplace" by Best Companies Group, a workplace culture and employee engagement expert, and COLOR Magazine, a leader in corporate inclusivity. Heartbeat is the only healthcare-focused advertising agency to be named to the distinguished company listing.

Key Points:

Leading healthcare marketing agency Heartbeat has been recognized as an "Inclusive Workplace" by Best Companies Group, a workplace culture and employee engagement expert.
NEW YORK, Jan. 10, 2023 /PRNewswire-PRWeb/ -- Leading healthcare marketing agency Heartbeat has been recognized as an "Inclusive Workplace" by Best Companies Group, a workplace culture and employee engagement expert, and COLOR Magazine, a leader in corporate inclusivity.
Heartbeat is the only healthcare-focused advertising agency to be named to the distinguished company listing.
Companies are evaluated based on their survey results, and only those that score high enough are eligible for the prestigious honor.

1798, a Fingerpaint company, recognized as DE&I Champion at the 2022 Manny Awards

Retrieved on:

Monday, April 25, 2022

Manny, Equity, Culture, Workplace, Diversity, Empathy, News, Patient, Workforce, Inc. (magazine), DE, Med Ad News, Multimedia, Industry, Film, Fingerpaint

SARATOGA SPRINGS, N.Y., April 25, 2022 /PRNewswire/ -- Fingerpaint ,biopharma's global commercialization partner for analytics-enabled integrated solutions, celebrated a milestone win at the 2022 Manny Awards, as 1798, Fingerpaint's market access and commercialization firm, was named Diversity, Equity & Inclusion Champion.

Key Points:

SARATOGA SPRINGS, N.Y., April 25, 2022 /PRNewswire/ -- Fingerpaint ,biopharma's global commercialization partner for analytics-enabled integrated solutions, celebrated a milestone win at the 2022 Manny Awards, as 1798, Fingerpaint's market access and commercialization firm, was named Diversity, Equity & Inclusion Champion.
This award recognizes 1798 as a leader in diversity and inclusion, embedding them in all aspects of its business operations.
All Fingerpaint companies share this commitment to creating and maintaining a workplace of diversity, equity, and inclusion.
"We could not be more honored to have 1798 receive this award," said Bill McEllen, Global President of Fingerpaint.

Dermavant Appoints Nancy Beesley to its Board of Directors

Retrieved on:

Tuesday, March 8, 2022

Dermavant Sciences, a clinical-stage biopharmaceutical company dedicated to developing and commercializing innovative therapeutics in immuno-dermatology, today announced the appointment of Nancy Beesley to its Board of Directors.

Key Points:

Dermavant Sciences, a clinical-stage biopharmaceutical company dedicated to developing and commercializing innovative therapeutics in immuno-dermatology, today announced the appointment of Nancy Beesley to its Board of Directors.
Nancy joins Dermavant with over 25 years of experience in commercializing and branding therapeutics for the treatment of various dermatological, ophthalmic, and neurological conditions and rare diseases.
I am delighted to be joining Dermavant at such a pivotal time in the companys history, said Nancy Beesley.
For more information, please visit www.dermavant.com , and follow us on Twitter ( @dermavant ) and LinkedIn ( Dermavant Sciences ).

Bill McEllen Named Global President of Fingerpaint

Retrieved on:

Thursday, December 16, 2021

SARATOGA SPRINGS, N.Y., Dec. 16, 2021 /PRNewswire/ -- Fingerpaint, biopharma's global commercialization partner for analytics-enabled integrated solutions, announced the appointment of Bill McEllen as global president effective immediately.

Key Points:

SARATOGA SPRINGS, N.Y., Dec. 16, 2021 /PRNewswire/ -- Fingerpaint, biopharma's global commercialization partner for analytics-enabled integrated solutions, announced the appointment of Bill McEllen as global president effective immediately.
A Fingerpaint partner, McEllen will continue to build on the exponential year-over-year growth the company has experienced, set in motion by Fingerpaint founder Ed Mitzen, who will serve as Fingerpaint's chairman and CEO.
Since joining Fingerpaint in 2016, McEllen has held a number of executive leadership positions, most recently as the head of all Fingerpaint full-service agencies.
Independent by design and built on a foundation of empathy, Fingerpaint is biopharma's global commercialization partner for analytics-enabled integrated solutions.

Fingerpaint Acquires London-Based Data and Analytics Firm Engage, Solidifying Its Global Footprint

Retrieved on:

Tuesday, December 14, 2021

Instagram, LinkedIn, Solution, McGregor, Empathy, Industry, Acquisition, News, Med Ad News, Patient, Therapy, Inc. (magazine), Multimedia, Twitter, Pharmaceutical industry, Fingerpaint, Facebook, Engage

SARATOGA SPRINGS, N.Y. and LONDON, Dec. 14, 2021 /PRNewswire/ -- Fingerpaint, biopharma's global commercialization partner for analytics-enabled integrated solutions, announced it acquired Engage, a London-based, award-winning, data and analytics–enabled healthcare marketing firm. Details of the transaction were not disclosed.

Key Points:

Engage will expand Fingerpaint's European footprint and complement the company's current data and analytics expertise.
"Strengthening our global infrastructure is reflective of the diversified biopharma industry we serve worldwide," said Ed Mitzen, founder of Fingerpaint.
Independent by design and built on a foundation of empathy, Fingerpaint is biopharma's global commercialization partner for analytics-enabled integrated solutions.
Engage, a Fingerpaint company, is a London-based, award-winning, data and analyticsenabled healthcare marketing firm.

Fingerpaint Acquires London-Based Data and Analytics Firm Engage, Solidifying Its Global Footprint

Retrieved on:

Tuesday, December 14, 2021

Solution, Twitter, Instagram, Patient, Acquisition, News, Med Ad News, Empathy, Inc. (magazine), LinkedIn, McGregor, Industry, Therapy, Pharmaceutical industry, Facebook, Fingerpaint, Engage

SARATOGA SPRINGS, N.Y. and LONDON, Dec. 14, 2021 /PRNewswire/ -- Fingerpaint, biopharma's global commercialization partner for analytics-enabled integrated solutions, announced it acquired Engage, a London-based, award-winning, data and analytics–enabled healthcare marketing firm. Details of the transaction were not disclosed.

Key Points:

Engage will expand Fingerpaint's European footprint and complement the company's current data and analytics expertise.
"Strengthening our global infrastructure is reflective of the diversified biopharma industry we serve worldwide," said Ed Mitzen, founder of Fingerpaint.
Independent by design and built on a foundation of empathy, Fingerpaint is biopharma's global commercialization partner for analytics-enabled integrated solutions.
Engage, a Fingerpaint company, is a London-based, award-winning, data and analyticsenabled healthcare marketing firm.

Fingerpaint Acquires MedThink, Adding Medical Communications to Its Suite of Capabilities

Retrieved on:

Tuesday, December 7, 2021

The acquisition of MedThink will bring extensive medical communications capabilities to Fingerpaint through 2 distinct divisions: MedThink SciCom, which harnesses deep scientific knowledge and extensive industry experience to develop solutions for medical affairs, medical communications, and publication groups; and MedThink Communications, which provides medical education and marketing services that influence perception and change the behavior of healthcare professionals to commercial teams of all sizes.

Key Points:

The acquisition of MedThink will bring extensive medical communications capabilities to Fingerpaint through 2 distinct divisions: MedThink SciCom, which harnesses deep scientific knowledge and extensive industry experience to develop solutions for medical affairs, medical communications, and publication groups; and MedThink Communications, which provides medical education and marketing services that influence perception and change the behavior of healthcare professionals to commercial teams of all sizes.
"Adding to our capabilities as our clients' needs evolve has always been a priority for Fingerpaint," said Ed Mitzen, founder of Fingerpaint.
"Joining Fingerpaint will accelerate our mission of moving minds, moving markets, and moving medicine by leveraging the company's capabilities at every step of the commercialization process," said Goudy.
MedThink, a Fingerpaint company, isa North Carolinabased company that empowers healthcare providers through medical communications built on a foundation of science, strategy, and innovation.

Heartbeat President, ECD, James Talerico Selected for 2021 PharmaVOICE 100

Retrieved on:

Monday, August 2, 2021

Heartbeat

NEW YORK, Aug. 2, 2021 /PRNewswire-PRWeb/ --Leading Healthcare advertising agency Heartbeat is proud to announce the selection of James Talerico, Heartbeat's President and Executive Creative Director, for inclusion in 2021's PharmaVOICE 100.

Key Points:

NEW YORK, Aug. 2, 2021 /PRNewswire-PRWeb/ --Leading Healthcare advertising agency Heartbeat is proud to announce the selection of James Talerico, Heartbeat's President and Executive Creative Director, for inclusion in 2021's PharmaVOICE 100.
PharmaVOICE is a respected industry publication serving as a resource for life-science executives and other healthcare-service professionals.
James joins the PharmaVOICE 100 as an already highly decorated creative talent and industry leader.
Heartbeat is immensely proud to work with a leader of James Talerico's caliber and wholeheartedly congratulates him for this well-deserved honor.